BSIM Therapeutics at the Lisbon Investor Conference
08 November, 2019
BSIM Therapeutics pitched its drug discovery program focusing on transthyretin amyloidosis (ATTR) to several international investors present at the “Health Startup Day”, the second day of the Lisbon Investor Conference. The event was organized by Hovione Capital and took place on November 8, 2019, at Museu do Oriente.